July 13, 2024

Presentations: Webinar Exploring the Potential of human Platelet Lysate

Download

Working Groups

We are pleased to share the highlights from our recent webinar on the applications and advancements of human platelet lysate, presented by the European Blood Alliance’s Working Group on Innovation and New Products. Held on June 6, 2024 from 13:00 to 14:30 CEST, the session looked into the significant role that human platelet lysate plays in modern medical practices and research.

The event featured expert insights from leaders in the field, including Ólafur Eysteinn Sigurjónsson, Hendrik Feys, Katharina Schallmoser, Erja Kerkelä, and David Lundy. Topics covered the standardization of human platelet lysate, regulatory considerations, good manufacturing practices for advanced therapy medicinal product (ATMP) manufacturing, and innovative treatments for hypoxic injuries.

We were delighted to host 122 attendees from 27 countries who participated in a series of keynote presentations, followed by a panel discussion and an interactive Q&A session. This webinar was particularly beneficial for medical researchers, clinical practitioners, and regulatory affairs professionals keen to engage with the latest developments across various medical domains.

Presentations are now available for those who wish to revisit the material or were unable to attend.

If you would like to watch the recording of the webinar, it is available with registration, by clicking here.

13:00 Opening

Peter O’Leary, Executive Director European Blood Alliance

13:05 Introduction

Ólafur Eysteinn Sigurjónsson, Head of Research and Development, Icelandic Blood Bank and Chair of EBA Innovation and New Products Working Group

13:15 Keynote Presentations
  Towards standardized human Platelet Lysate

Hendrik Feys, Principal Investigator, Red Cross Flanders

  Regulatory aspects

Katharina Schallmoser, Professor for Transfusion Medicine, Paracelsus Medical University of Salzburg, Austria

  Example of GMP production for ATMP manufacturing

Erja Kerkelä, Development Manager, Finnish Red Cross Blood Service

  Treatment of hypoxic injuries

David Lundy, Associate Professor, Taipei Medical University

14:15 Panel Discussion and Q&A
  Q&A session, allowing participants to engage directly with the experts
14:35 Closing

Ólafur Eysteinn Sigurjónsson, Chair Innovation and New Products Working Group

Download Presentations

Download

More resources

Expand the map
  • 17 million donations
  • 445 million population
ES PT GR LT DK MT IT DE SE NO FI EE LV CH HU FR GB NL HR SI AT MK IE IS BE LU